George Vlachogiannis: CRC screening adherence among Asian Americans using multi-target stool DNA testing
George Vlachogiannis, Managing Editor at Cancer Control, shared an article by Mallik Greene, et al. on LinkedIn:
“A recent study published in Cancer Control sheds light on colorectal cancer (CRC) screening adherence among Asian Americans using multi-target stool DNA (mt-sDNA) testing.
An analysis of over 336,000 first-time users revealed a notably high adherence rate of 71%, outperforming traditional screening rates reported for this population. Adherence was highest among those under GI care (82%) and those who received digital outreach (SMS/email).
However, disparities persisted—patients with Medicaid, non-English speakers (especially Spanish), and those without specialist care showed significantly lower adherence. These findings underscore the critical need for targeted digital and provider-led interventions to close screening gaps and reduce CRC burden in a growing and underserved population.”
Real-World Adherence to Multi-Target Stool DNA Testing for Colorectal Cancer Among Asian Americans.
Authors: Mallik Greene, et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023